Immediate Impact

8 from Science/Nature 86 standout
Sub-graph 1 of 17

Citing Papers

Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data
2021 Standout
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
2019 Standout
9 intermediate papers

Works of David Walde being referenced

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout

Author Peers

Author Last Decade Papers Cites
David Walde 3673 879 196 1381 1022 22 4.7k
Robert Lim 3023 526 66 1359 1046 52 4.4k
H. Au 2869 477 83 1045 964 23 3.4k
Donna M. Gress 2405 1994 120 2009 931 11 5.3k
Carl Zuelke 2143 1119 105 791 680 13 3.3k
James R. Egner 2215 1775 107 1719 738 21 4.9k
M. Christine Cripps 4440 1031 42 1252 1526 24 5.4k
Peter G. Tarassoff 5595 1261 60 1790 1841 20 7.0k
Henry Q. Xiong 2812 787 42 1285 1031 39 4.3k
Frederick L. Greene 3677 2408 140 2125 1040 43 6.6k
Lola Rahib 4829 1323 214 1089 2175 36 6.7k

All Works

Loading papers...

Rankless by CCL
2026